SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

Clinical trial NCT02967679 · COMPLETED

Trial details

NCT number: NCT02967679
Sponsor: MedDay Pharmaceuticals SA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Inflammatory Demyelinating Polyneuropathy Peripheral Neuropathy Charcot-Marie-Tooth Disease Charcot-Marie-Tooth Disease Type 1A Charcot-Marie-Tooth Disease, Type 1B Anti-MAG Neuropathy

Start date: 2016-12-05
Primary completion: 2019-03-18
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.